Advertisement
Screener

BECTON, DICKINSON AND COMPANY (BDX) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

BECTON, DICKINSON AND COMPANY Financing Cash Flow

BECTON, DICKINSON AND COMPANY (BDX) reported Financing Cash Flow of -$302.00 million for the 3-month period ending 2025-12-31, per its 10-Q filed 2026-02-09.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-02-09

  • BECTON, DICKINSON AND COMPANY net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$302.00M.
  • BECTON, DICKINSON AND COMPANY net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$809.00M, a 752.42% decline year-over-year.
  • BECTON, DICKINSON AND COMPANY net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was -$841.00M, a 175.09% decline year-over-year.
  • BECTON, DICKINSON AND COMPANY net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was -$39.00M, a 102.29% decline year-over-year.
  • BECTON, DICKINSON AND COMPANY net cash provided by (used in) financing activities for fiscal 2025 was -$3.62B, a 273.31% decline from fiscal 2024.
  • BECTON, DICKINSON AND COMPANY net cash provided by (used in) financing activities for fiscal 2024 was $2.09B.
  • BECTON, DICKINSON AND COMPANY net cash provided by (used in) financing activities for fiscal 2023 was -$1.96B.
  • BECTON, DICKINSON AND COMPANY net cash provided by (used in) financing activities for fiscal 2021 was -$3.31B, a 15127.27% decline from fiscal 2020.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2025-12-31-$302.00M
10-Q · filed 2026-02-09
-$1.11B
derived: sum of 2 quarters · filed 2026-02-09
-$1.95B
derived: sum of 3 quarters · filed 2026-02-09
-$1.99B
derived: sum of 4 quarters · filed 2026-02-09
2025-09-30-$809.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25
-$1.65B
derived: sum of 2 quarters · filed 2025-11-25
-$1.69B
derived: sum of 3 quarters · filed 2025-11-25
-$3.62B
10-K · filed 2025-11-25
2025-06-30-$841.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07
-$880.00M
derived: sum of 2 quarters · filed 2025-08-07
-$2.81B
10-Q · filed 2025-08-07
-$2.68B
derived: sum of 4 quarters · filed 2026-02-09
2025-03-31-$39.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-01
-$1.97B
10-Q · filed 2025-05-01
-$1.84B
derived: sum of 3 quarters · filed 2026-02-09
-$723.00M
derived: sum of 4 quarters · filed 2026-02-09
2024-12-31-$1.93B
10-Q · filed 2026-02-09
-$1.80B
derived: sum of 2 quarters · filed 2026-02-09
-$684.00M
derived: sum of 3 quarters · filed 2026-02-09
$1.02B
derived: sum of 4 quarters · filed 2026-02-09
2024-09-30$124.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25
$1.24B
derived: sum of 2 quarters · filed 2025-11-25
$2.95B
derived: sum of 3 quarters · filed 2025-11-25
$2.09B
10-K · filed 2025-11-25
2024-06-30$1.12B
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07
$2.83B
derived: sum of 2 quarters · filed 2025-08-07
$1.96B
10-Q · filed 2025-08-07
$966.00M
derived: sum of 4 quarters · filed 2025-11-25
2024-03-31$1.71B
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-01
$843.00M
10-Q · filed 2025-05-01
-$154.00M
derived: sum of 3 quarters · filed 2025-11-25
-$1.95B
derived: sum of 4 quarters · filed 2025-11-25
2023-12-31-$862.00M
10-Q · filed 2025-02-06
-$1.86B
derived: sum of 2 quarters · filed 2025-11-25
-$3.65B
derived: sum of 3 quarters · filed 2025-11-25
-$2.28B
derived: sum of 4 quarters · filed 2025-11-25
2023-09-30-$997.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25
-$2.79B
derived: sum of 2 quarters · filed 2025-11-25
-$1.42B
derived: sum of 3 quarters · filed 2025-11-25
-$1.96B
10-K · filed 2025-11-25
2023-06-30-$1.79B
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-01
-$425.00M
derived: sum of 2 quarters · filed 2024-08-01
-$959.00M
10-Q · filed 2024-08-01
2023-03-31$1.37B
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-02
$835.00M
10-Q · filed 2024-05-02
2022-12-31-$534.00M
10-Q · filed 2024-02-01
2022-03-31$1.13B
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-05
$804.00M
10-Q · filed 2022-05-05
-$338.00M
derived: sum of 3 quarters · filed 2023-02-02
-$1.61B
derived: sum of 4 quarters · filed 2023-02-02
2021-12-31-$327.00M
10-Q · filed 2023-02-02
-$1.47B
derived: sum of 2 quarters · filed 2023-02-02
-$2.74B
derived: sum of 3 quarters · filed 2023-02-02
-$3.04B
derived: sum of 4 quarters · filed 2023-02-02
2021-09-30-$1.14B
derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24
-$2.41B
derived: sum of 2 quarters · filed 2021-11-24
-$2.71B
derived: sum of 3 quarters · filed 2022-05-05
-$3.31B
10-K · filed 2021-11-24
2021-06-30-$1.27B
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05
-$1.57B
derived: sum of 2 quarters · filed 2022-05-05
-$2.16B
10-Q · filed 2021-08-05
-$3.37B
derived: sum of 4 quarters · filed 2022-05-05
2021-03-31-$301.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-05
-$893.00M
10-Q · filed 2022-05-05
-$2.10B
derived: sum of 3 quarters · filed 2022-05-05
-$2.08B
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-$592.00M
10-Q · filed 2022-02-03
-$1.80B
derived: sum of 2 quarters · filed 2022-02-03
-$1.78B
derived: sum of 3 quarters · filed 2022-02-03
-$157.00M
derived: sum of 4 quarters · filed 2022-02-03
2020-09-30-$1.21B
derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24
-$1.19B
derived: sum of 2 quarters · filed 2021-11-24
$435.00M
derived: sum of 3 quarters · filed 2021-11-24
$22.00M
10-K · filed 2021-11-24
2020-06-30$20.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05
$1.64B
derived: sum of 2 quarters · filed 2021-08-05
$1.23B
10-Q · filed 2021-08-05
$307.00M
derived: sum of 4 quarters · filed 2021-11-24
2020-03-31$1.62B
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-06
$1.21B
10-Q · filed 2021-05-06
$287.00M
derived: sum of 3 quarters · filed 2021-11-24
-$481.00M
derived: sum of 4 quarters · filed 2021-11-24
2019-12-31-$413.00M
10-Q · filed 2021-02-04
-$1.34B
derived: sum of 2 quarters · filed 2021-11-24
-$2.10B
derived: sum of 3 quarters · filed 2021-11-24
-$2.90B
derived: sum of 4 quarters · filed 2021-11-24
2019-09-30-$923.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24
-$1.69B
derived: sum of 2 quarters · filed 2021-11-24
-$2.49B
derived: sum of 3 quarters · filed 2021-11-24
-$3.22B
10-K · filed 2021-11-24
2019-06-30-$768.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-06
-$1.57B
derived: sum of 2 quarters · filed 2020-08-06
-$2.30B
10-Q · filed 2020-08-06
-$3.31B
derived: sum of 4 quarters · filed 2020-11-25
2019-03-31-$798.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07
-$1.53B
10-Q · filed 2020-05-07
-$2.54B
derived: sum of 3 quarters · filed 2020-11-25
-$3.15B
derived: sum of 4 quarters · filed 2020-11-25
2018-12-31-$734.00M
10-Q · filed 2020-02-06
-$1.74B
derived: sum of 2 quarters · filed 2020-11-25
-$2.36B
derived: sum of 3 quarters · filed 2020-11-25
-$2.73B
derived: sum of 4 quarters · filed 2020-11-25
2018-09-30-$1.01B
derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25
-$1.62B
derived: sum of 2 quarters · filed 2020-11-25
-$2.00B
derived: sum of 3 quarters · filed 2020-11-25
-$58.00M
10-K · filed 2020-11-25
2018-06-30-$616.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-06
-$989.00M
derived: sum of 2 quarters · filed 2019-08-06
$949.00M
10-Q · filed 2019-08-06
$493.00M
derived: sum of 4 quarters · filed 2019-11-27
2018-03-31-$373.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-09
$1.56B
10-Q · filed 2019-05-09
$1.11B
derived: sum of 3 quarters · filed 2019-11-27
$14.40B
derived: sum of 4 quarters · filed 2019-11-27
2017-12-31$1.94B
10-Q · filed 2019-02-05
$1.48B
derived: sum of 2 quarters · filed 2019-11-27
$14.78B
derived: sum of 3 quarters · filed 2019-11-27
$13.87B
derived: sum of 4 quarters · filed 2019-11-27
2017-09-30-$456.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27
$12.84B
derived: sum of 2 quarters · filed 2019-11-27
$11.93B
derived: sum of 3 quarters · filed 2019-11-27
$10.98B
10-K · filed 2019-11-27
2017-06-30$13.29B
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-02
$12.39B
derived: sum of 2 quarters · filed 2018-08-02
$11.43B
10-Q · filed 2018-08-02
$10.95B
derived: sum of 4 quarters · filed 2018-11-21
2017-03-31-$906.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-03
-$1.86B
10-Q · filed 2018-05-03
-$2.35B
derived: sum of 3 quarters · filed 2018-11-21
-$3.05B
derived: sum of 4 quarters · filed 2018-11-21
2016-12-31-$955.00M
10-Q · filed 2018-02-06
-$1.44B
derived: sum of 2 quarters · filed 2018-11-21
-$2.14B
derived: sum of 3 quarters · filed 2018-11-21
-$2.57B
derived: sum of 4 quarters · filed 2018-11-21
2016-09-30-$485.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-21
-$1.19B
derived: sum of 2 quarters · filed 2018-11-21
-$1.62B
derived: sum of 3 quarters · filed 2018-11-21
-$1.76B
10-K · filed 2018-11-21
2016-06-30-$700.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03
-$1.13B
derived: sum of 2 quarters · filed 2017-08-03
-$1.28B
10-Q · filed 2017-08-03
-$1.75B
derived: sum of 4 quarters · filed 2017-11-22
2016-03-31-$431.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-02
-$576.00M
10-Q · filed 2017-05-02
-$1.05B
derived: sum of 3 quarters · filed 2017-11-22
-$1.78B
derived: sum of 4 quarters · filed 2017-11-22
2015-12-31-$145.00M
10-Q · filed 2017-02-02
-$622.00M
derived: sum of 2 quarters · filed 2017-11-22
-$1.35B
derived: sum of 3 quarters · filed 2017-11-22
2015-09-30-$477.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-22
-$1.20B
derived: sum of 2 quarters · filed 2017-11-22
$6.19B
10-K · filed 2017-11-22
2015-06-30-$725.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-04
$6.67B
10-Q · filed 2016-08-04
2015-03-31$7.39B
10-Q · filed 2016-05-06
2014-09-30-$807.00M
10-K · filed 2016-11-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
DEXCOM INC (DXCM)United States$33.004B25.42
BOSTON SCIENTIFIC CORP (BSX)United States$64.781B17.29
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
3M CO (MMM)United States$86.404B27.87
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73